Target intelligence / Profile preview

Myosin-IIIa (MYO3A)

Target
MYO3A
Molecular classification
Enzyme (due to its kinase domain and ATPase function), Actin motor protein (unconventional myosin)
01

Overview

Myosin-IIIa is an unconventional myosin motor protein that also contains a protein kinase domain. It walks toward the plus end of actin filaments and is highly expressed in sensory cells, notably in the stereocilia of the inner ear and photoreceptor cells in the retina. MYO3A plays critical roles in regulating actin-rich cellular protrusions by transporting actin-bundling proteins, such as espin, to the tips of filopodia, microvilli, and stereocilia. Its activity is regulated through autophosphorylation of its kinase and motor domains, which affects both motor properties and subcellular localization. Pathogenic mutations in MYO3A are causative of hereditary forms of nonsyndromic deafness, due to impaired regulation of stereocilia length and function. No drugs currently target MYO3A directly, and it is not considered a therapeutic target, but it is a gene of clinical interest for genetic screening in hearing loss disorders.

Other names
MYO3ADFNA90DFNB30Epididymis secretory sperm binding proteinMyosin-IIIa
02

Mechanism of action

Not applicable; there are no known drugs or therapeutic inhibitors/activators targeting MYO3A

03

Biological functions

Actin-based motility (plus-end directed movement along actin filaments)Regulation of actin protrusion length, especially in stereocilia and microvilliProtein phosphorylation (intramolecular kinase activity)Transport of binding partners (e.g., espin)
04

Disease associations

Deafness (sensorineural, nonsyndromic, hereditary: DFNB30, DFNA90)Retinal/photoreceptor cell dysfunction (suggested by expression and function in photoreceptors)Other
05

Biomarkers

Mutations in MYO3A are used as genetic biomarkers for nonsyndromic deafness (DFNB30, DFNA90)

Beyond the preview

Go deeper on Myosin-IIIa (MYO3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin-IIIa (MYO3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call